Clinical Trials Browser

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT04458597 2025-08-01

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

Phase NA Completed

23 enrolled

Sarcoma

Carcinosarcoma, Adenocarcinoma, Clear Cell, Carcinoma, Endometrioid, Cystadenocarcinoma, Serous

NCT04575961 2025-05-23

PERCEPTION

Phase 2 Active not recruiting

33 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT05289648 2024-12-19

NIREC

Phase EARLY_PHASE1 Withdrawn

Gynecologic

Uterine Neoplasms, Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT04716686 2024-01-05

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Phase 2 Recruiting

83 enrolled

Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT04055038 2019-08-13

EPITOC

Phase 2/3 Unknown

164 enrolled

Gynecologic

Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT02834169 2017-08-22

RENAPE

Unknown

2,171 enrolled

Pseudomyxoma Peritonei, Cystadenocarcinoma, Serous, Desmoplastic Small Round Cell Tumor

NCT00515073 2014-07-03

Papillary Serous Carcinoma of the Endometrium

Phase 2 Completed

30 enrolled 5 charts

Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

Clinical Trials

CAN-STAMP

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

PERCEPTION

NIREC

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

EPITOC

RENAPE

Papillary Serous Carcinoma of the Endometrium